peritoneal

1.Objective To evaluate the incidence of depress in hemodia lysis and peritoneal dialysis uremia patients.

目 评价进行血液透析和腹膜透析治疗尿毒症患 者抑郁症发病情况。

2.Conclusion： The monocaryon - macrophage toxic action in peritoneal fluid was down obviously in duration of pregnancy placental infection by MCMV.

论：孕期胎盘MCMV感染明显降低孕鼠腹腔液中单核-巨噬细胞胞毒作用。

3.Conclusion It is shown that fructosamine and AGEs were significantly higher in patients on CAPD,and they could not be effectively removed by peritoneal dialysis.

论 提示糖化产物在腹膜透析患者体内增多，腹膜透析清除效果差，且可影响腹膜转运。

4.Peritoneal lavage,poly-tube drainge, omental bursa incision, pancreatic envelope and pancreatic bed brisement were made mainly.

果:临床疗效满意,治愈7例,1例死于ARDS。

5.The results provided clinical basis for cisplatin isotone peritoneal chemotherapy as well as established a method for the research of drug release, absorbed dose and absortive rate.

其呆不仅给临床顺铂腹腔化疗提供理论依据而且提出研究体内药物释放，药物吸收量及药物吸收速率方法。

6.At present, all over the world, about one hundred thousand uraemic patients, which is about 15 precent of the total dialysis population are accepting peritoneal dialysis treatment.

腹膜透析是通过腹膜这层天然生物膜，腹腔中腹透液和腹膜毛细血管内血液之间进行水和溶质转运与交换过程。目前全世界约有10万名终末期透析患者接受腹膜透析治疗，约占透析人口总数15%。